Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of PTGES mRNA | increases expression | 16788091
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PTGES mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
[Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 18922899
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PTGES mRNA | affects expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PTGES mRNA | increases expression | 15336504
|
C459604 |
candoxin |
candoxin results in decreased expression of PTGES mRNA | decreases expression | 16309724
|
C105934 |
celecoxib |
[celecoxib co-treated with docetaxel] results in decreased expression of PTGES protein | affects cotreatment|decreases expression | 16052515
|
C105934 |
celecoxib |
celecoxib results in decreased expression of PTGES mRNA | decreases expression | 16273290
|
D003474 |
Curcumin |
Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGES mRNA] | decreases reaction|increases expression | 19243473
|
C014347 |
decitabine |
decitabine results in increased expression of PTGES mRNA | increases expression | 15251184
|
C014347 |
decitabine |
[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 15251184
|
D003840 |
Deoxycholic Acid |
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 16556975
|
C067311 |
docetaxel |
[celecoxib co-treated with docetaxel] results in decreased expression of PTGES protein | affects cotreatment|decreases expression | 16052515
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of PTGES mRNA | increases expression | 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PTGES mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PTGES mRNA | increases expression | 17942748
|
C030691 |
gluconic acid |
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 16556975
|
C051890 |
irinotecan |
irinotecan metabolite results in increased expression of PTGES mRNA | increases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in increased expression of PTGES mRNA | increases expression | 15956246
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PTGES mRNA | increases expression | 17927823
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PTGES protein | increases expression | 17927823
|
D008070 |
Lipopolysaccharides |
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGES mRNA] | decreases reaction|increases expression | 17927823
|
D008070 |
Lipopolysaccharides |
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGES protein] | decreases reaction|increases expression | 17927823
|
D008070 |
Lipopolysaccharides |
Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGES mRNA] | decreases reaction|increases expression | 19243473
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PTGES mRNA | increases expression | 19243473
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of PTGES protein | increases expression | 19692487
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in increased expression of PTGES protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 19692487
|
D018021 |
Lithium Chloride |
PTGES protein promotes the reaction [Lithium Chloride results in decreased expression of AQP2 mRNA] | decreases expression|increases reaction | 19692487
|
D018021 |
Lithium Chloride |
PTGES protein promotes the reaction [Lithium Chloride results in decreased expression of AQP2 protein] | decreases expression|increases reaction | 19692487
|
D018021 |
Lithium Chloride |
PTGES protein promotes the reaction [Lithium Chloride results in decreased expression of SLC12A1 protein] | decreases expression|increases reaction | 19692487
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of PTGES mRNA | increases expression | 20713471
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of PTGES mRNA | decreases expression | 11830524
|
C528911 |
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide results in increased expression of PTGES mRNA | increases expression | 18287210
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PTGES mRNA | affects binding|increases activity|increases expression | 19710929
|
D015232 |
Dinoprostone |
[GPX2 protein affects the expression of PTGES protein] which affects the metabolism of Dinoprostone | affects expression|affects metabolic processing | 18479189
|
D015232 |
Dinoprostone |
[Lithium Chloride results in increased expression of PTGES protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 19692487
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of PTGES mRNA | affects cotreatment|decreases expression | 19059307
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGES mRNA] | decreases reaction|increases expression | 17927823
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGES protein] | decreases reaction|increases expression | 17927823
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of PTGES mRNA | increases expression | 19244175
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of PTGES mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PTGES mRNA | affects expression | 17555576
|
C011363 |
terephthalic acid |
terephthalic acid results in increased expression of PTGES mRNA | increases expression | 16621493
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PTGES mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 15251184
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PTGES mRNA | increases expression | 15328365
|
D013755 |
Tetradecanoylphorbol Acetate |
[Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 18922899
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PTGES mRNA | increases expression | 16788091 16604517
|
D014260 |
Triclosan |
Triclosan inhibits the reaction [TNF protein results in increased expression of PTGES mRNA] | decreases reaction|increases expression | 15642051
|
D014260 |
Triclosan |
Triclosan inhibits the reaction [TNF protein results in increased expression of PTGES protein] | decreases reaction|increases expression | 15642051
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PTGES mRNA | increases expression | 15379904
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of PTGES mRNA | increases expression | 17170073
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of PTGES mRNA | affects cotreatment|increases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of PTGES mRNA | increases expression | 19244175
|
D015054 |
Zymosan |
Zymosan results in increased expression of PTGES mRNA | increases expression | 15708354
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.19 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.14 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.14 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.61 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.21 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.58 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.54 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
7.96 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.96 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
6.46 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.46 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.46 | 14692618 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
6.42 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.42 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.72 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.72 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
9.46 | 19003578 16215675 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
9.46 | 17942926 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.26 | 17451421 17308373 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.72 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.34 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
6.21 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
6.21 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
6.21 | 16162502 16183991 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.87 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.98 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
7.98 | 18664788 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.30 | 17497229 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.27 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
5.28 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.12 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
20.74 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
20.74 | 18287210 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
20.74 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
20.74 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
20.74 | 16872482 15944321 15142272 15188379 17659584 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.42 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.42 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.23 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
9.90 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
9.90 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
9.90 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.04 | 18177632 17507914 20603192 18985861 18775368 17688650 17157402 15238991 19460635 18558336 16609825 18316065 18940202 18396377 19232924 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
9.94 | 16142846 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
9.94 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.06 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.39 | 15976003 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.89 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
19.35 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
19.35 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
19.35 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
19.35 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.43 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.26 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.26 | 8888407 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.13 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
9.15 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
9.15 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.63 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
6.58 | 18462866 18593918 16243823 19250217 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
6.58 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
docetaxel |
6.58 | 16264153 17369602 19526202 15567936 15692762 16495393 18628466 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.58 | 12948864 17018787 14630087 18497071 17289903 19861407 16675129 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
6.58 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
6.58 | 17049068 17595753 15572757 17242785 17952589 15775269 17893378 16837676 15758505 17440819 16912660 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.58 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.58 | 20859285 20005174 17440819 19142967 19221464 19084267 19410462 18425577 19487384 19115204 17893378 11161223 21138602 19289846 17049068 18351453 19288272 16202921 16818667 19103187 17242785 15668708 17261762 18855134 16873071 20135344 19189210 18984771 18997820 19011961 19066611 19155303 20390343 18629630 20065188 19200415 18821012 15565566 18815881 19189212 19059307 21152245 16273361 20544844 19244106 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.58 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.58 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.24 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.00 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.11 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.59 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
12.42 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
12.42 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
12.42 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.16 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.80 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
8.18 | 14691202 16217749 15073043 11135700 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.18 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.18 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.18 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.18 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.24 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.73 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
docetaxel |
5.73 | 11894018 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.51 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
4.02 | 16369983 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.81 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
13.15 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
13.15 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
13.15 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
13.15 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.15 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.48 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.48 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.17 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.75 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.75 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.88 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.12 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
14.12 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.12 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
14.12 | 16192471 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.24 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.58 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.87 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.88 | 16919318 16105132 17110522 17681005 11677210 17333356 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.88 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.80 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.25 | 15340226 16354765 8697196 15668235 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.25 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.27 | 15800139 |
MESH:D003092 |
Colitis |
|
Curcumin |
20.01 | 16782535 16804969 18200517 |
MESH:D003092 |
Colitis |
|
resveratrol |
20.01 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
20.01 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
20.01 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.23 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
13.13 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
13.13 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
13.13 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Deoxycholic Acid |
13.13 | 16213893 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
13.13 | 17287894 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
13.13 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
6.08 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
6.08 | 11197048 18349538 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
6.08 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
6.08 | 16391804 18259882 15273666 17159606 18509181 16303861 17454858 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
6.08 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.56 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Triclosan |
8.56 | 19283420 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.55 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.52 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.85 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.84 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.84 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.84 | 8800419 17551590 9125849 9664655 9142499 16925845 9224671 14991402 9211117 10589399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
6.84 | 17688650 16575769 8888407 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
6.84 | 19769572 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.77 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.02 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.87 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.26 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.49 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
4.09 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.09 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
24.92 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
24.92 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
24.92 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
24.92 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
24.92 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.22 | 11488427 7237001 10446763 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
5.56 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.56 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.56 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.50 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.72 | 17351913 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.72 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.34 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
22.97 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
22.97 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
22.97 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
22.97 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
22.97 | 8273558 15177302 8113982 16716910 7812673 11698051 9599246 |
MESH:D004487 |
Edema |
|
Zymosan |
22.97 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.74 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.74 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.18 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
19.18 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
19.18 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
19.18 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.75 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.08 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.08 | 17893378 16202921 19155303 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.08 | 16569247 |
MESH:D004715 |
Endometriosis |
|
celecoxib |
8.35 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.35 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.04 | 15328337 15821434 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.50 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.81 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.56 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.75 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.29 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.95 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.71 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.86 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.86 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
docetaxel |
6.86 | 16337965 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.96 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.96 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
32.12 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
32.12 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
32.12 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
32.12 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
32.12 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
32.12 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
32.12 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.02 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.11 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.53 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.79 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Dinoprostone |
8.62 | 16997862 11852909 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
8.62 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.17 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.83 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.58 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
12.83 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.83 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.83 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.93 | 16904648 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.35 | 18462866 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
6.52 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.52 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.23 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
11.62 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
11.62 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
11.62 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.80 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.03 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.03 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
10.03 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.29 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.22 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.22 | 17162251 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.08 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.02 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.36 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.12 | 19176532 19772884 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.12 | 15340226 12621046 16120746 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.69 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.57 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.67 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.83 | 16876885 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
8.85 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
8.85 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.51 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
11.82 | 19797860 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
11.82 | 16354765 8697196 18606429 16959395 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
7.38 | 16793879 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.38 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
8.34 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.34 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.22 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.88 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.70 | 16873680 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
4.76 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.76 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.00 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.46 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.30 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.14 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
10.05 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
10.05 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Triclosan |
10.05 | 20821571 |
MESH:D007249 |
Inflammation |
|
Curcumin |
25.34 | 17151092 18403477 16956363 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
25.34 | 17237260 17255318 12878042 9205823 17963957 |
MESH:D007249 |
Inflammation |
|
resveratrol |
25.34 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
25.34 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
25.34 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
25.34 | 7812673 7562506 8273558 15177302 11698051 |
MESH:D007249 |
Inflammation |
|
Triclosan |
25.34 | 9584910 20507366 |
MESH:D007249 |
Inflammation |
|
Zymosan |
25.34 | 8014878 11289658 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.06 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
16.53 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
16.53 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
16.53 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.42 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.42 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.42 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.91 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.30 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.48 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.88 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.88 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.42 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
5.42 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.57 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.44 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.44 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
10.07 | 18555241 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
10.07 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
13.49 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
13.49 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
13.49 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
13.49 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
8.71 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
8.71 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.95 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.17 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.17 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
14.17 | 19117987 17236224 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.17 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
8.14 | 19850784 16467208 16968895 17050201 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.14 | 17679729 19387464 18460780 18206229 18704418 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.14 | 17596541 19850784 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
8.14 | 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.10 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
11.43 | 12712474 19225113 16330433 11161223 16331271 16823087 17107899 12679006 11468182 17649720 15748426 17869043 19075265 16966277 19035177 12018890 19642359 15622746 9834237 17217047 16112521 17712046 15336539 15213294 16891316 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
11.43 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
11.43 | 19075265 17506722 17339181 16823087 17217047 12679006 17712046 19029980 17649720 19225113 9834237 17301526 16140955 16766008 19035177 17368321 19642359 16788101 17361223 17294898 17107899 15748426 16891316 16331271 16935935 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
10.59 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
10.59 | 16106398 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.34 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.06 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.90 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
14.70 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
14.70 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
14.70 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
14.70 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
14.70 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
14.70 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
14.70 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
14.70 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
14.70 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
4.44 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
4.44 | 15816358 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
12.72 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
12.72 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
12.72 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
12.72 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.39 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Deoxycholic Acid |
12.39 | 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
12.39 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.39 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.08 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
2.94 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.90 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.67 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
9.93 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
9.93 | 19359593 18462866 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
9.93 | 21163286 15390079 11893704 7750092 16337739 20970405 17909032 1399818 20512841 16271038 6695378 9230183 10545420 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
9.93 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
9.93 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.93 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
9.93 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
6.94 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
6.94 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.97 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.58 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.35 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
8.82 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
8.82 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
25.00 | 19196722 12104042 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
25.00 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
25.00 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
25.00 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
25.00 | 19196723 19196722 16827153 14580682 11731420 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
25.00 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Triclosan |
25.00 | 15358634 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.44 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.44 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.64 | 17453147 |
MESH:D008545 |
Melanoma |
|
Curcumin |
11.58 | 18462866 17885582 |
MESH:D008545 |
Melanoma |
|
decitabine |
11.58 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
docetaxel |
11.58 | 12417787 |
MESH:D008545 |
Melanoma |
|
resveratrol |
11.58 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
11.58 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
11.58 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.83 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.82 | 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.08 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.65 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.06 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.94 | 18765137 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
4.93 | 11304026 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.19 | 15863610 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.65 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
25.00 | 11468182 19549372 19417148 15949261 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
25.00 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
25.00 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
25.00 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
25.00 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
25.00 | 17935668 17049120 14749477 16490592 17164350 16267019 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.88 | 10479408 15259001 15241586 15834315 12130978 18160304 10890648 15213630 12879239 17724436 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
11.23 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
11.23 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.16 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.71 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.31 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
15.88 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
15.88 | 19157545 18608210 19010910 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
15.88 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
15.88 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.23 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.23 | 17188708 17015251 16456233 16525036 16317513 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.09 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.09 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.35 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.35 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.40 | 17322642 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.19 | 16343187 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
9.21 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
9.21 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
5.46 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.46 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.40 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
7.21 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.21 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.21 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.66 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
16.32 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
16.32 | 12497104 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
16.32 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.38 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.38 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.38 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.38 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.27 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.81 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.81 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
10.81 | 8888407 16359493 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.30 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.52 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.38 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.07 | 17929310 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.28 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.28 | 20558911 |
MESH:D010003 |
Osteoarthritis |
|
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
5.45 | 18287210 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
6.11 | 18500342 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
6.68 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.68 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.12 | 17893378 15579764 17823083 15758505 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
9.12 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
13.70 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
13.70 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
13.70 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
13.70 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.70 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.63 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
14.89 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
14.89 | 19401701 17440100 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
14.89 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.89 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
14.89 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.36 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.95 | 18922899 12065085 18404319 8330346 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.84 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.89 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.54 | 18760300 19641140 17371808 18557954 15979727 15259001 11985352 17826846 18977430 19088179 14761945 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.53 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.20 | 11605937 12224865 |
MESH:D011141 |
Polyuria |
marker/mechanism |
|
| 19692487 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
5.64 | 19692487 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.22 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
14.22 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.22 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
14.22 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.38 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.57 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
4.04 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
4.04 | 17908994 15570007 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
4.04 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
4.04 | 11398177 15129424 18226269 10851300 18769126 18156803 12497104 |
MESH:D011471 |
Prostatic Neoplasms |
|
docetaxel |
4.04 | 18824434 16644109 16520278 19103299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.04 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
4.04 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
4.04 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.04 | 17636462 16731767 17718901 17675339 17804756 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
4.04 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
4.04 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.28 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.96 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.18 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.44 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.22 | 19168576 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.19 | 15770314 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.22 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.98 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.98 | 17058453 16314181 16317513 15827377 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.70 | 10666014 18379247 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.50 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.50 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
16.63 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
16.63 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
16.63 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.81 | 18462866 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.62 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.02 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.51 | 3137016 11738929 1511512 14763951 11044598 16876388 17978042 15475178 |
MESH:D018805 |
Sepsis |
|
Curcumin |
8.73 | 18389075 |
MESH:D018805 |
Sepsis |
|
Zymosan |
8.73 | 11441115 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.35 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
16.10 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
16.10 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.10 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
16.10 | 18404319 8985016 12065085 8330346 11807781 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.10 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.36 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.36 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.68 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.51 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.18 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
7.78 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
7.78 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
7.78 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
docetaxel |
7.78 | 16557585 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
7.78 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.78 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
3.19 | 16631530 19188055 |
MESH:D020521 |
Stroke |
|
Raloxifene |
7.79 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
7.79 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.17 | 16321402 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.86 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.29 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.86 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.30 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Triclosan |
11.30 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
10.48 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
10.48 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
10.48 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.51 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.51 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.89 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.89 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.61 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.87 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.01 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.17 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
18.00 | 20435036 12845720 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
18.00 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
18.00 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
18.00 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
18.00 | 8653321 17572228 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
terephthalic acid |
18.00 | 16896691 16621493 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.30 | 8888407 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.91 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.52 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.52 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
14.26 | 18645019 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
14.26 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
14.26 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.63 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.63 | 16752155 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.04 | 11006244 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.23 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.85 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.22 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.96 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.72 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.19 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.89 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.67 | 16287080 |